The Swiss Times - Swiss News in English

Sandoz Successfully Completes Acquisition of Biosimilar Cimerli

  • By The Swiss Times
  • 4 March 2024

Sandoz finalizes the acquisition of Cimerli, a biosimilar for the eye medication Lucentis, enhancing its ophthalmology portfolio in the US market.

Sandoz Successfully Completes Acquisition of Biosimilar Cimerli
Keystone/SDA – URS FLUEELER

Our story reporting this news was published over a month ago. It has now been confirmed.

The generics specialist Sandoz has completed the takeover of the biosimilar Cimerli in the USA. Sandoz had already announced the takeover plans in January.

Sandoz has acquired the biosimilar of the eye drug Lucentis from the US biotech company Coherus BioSciences for 170 million US dollars in cash. The Basel-based company announced the transaction was completed faster than expected on Monday. The deal was initially expected to be completed in the year’s first half.

The acquisition strengthens Sandoz’s US market position and ophthalmology business. Cimerli is a ranibizumab biosimilar that is interchangeable with the original drug Lucentis in all approved indications. It has been approved in the US since August 2022 and was launched there in October 2022.

The original preparation Lucentis is marketed by the two pharmaceutical companies Roche and Novartis. Roche is responsible for the US market, and Novartis is for the other markets.

©Keystone/SDA

Most Read

Sunday, April 7 – Round Up

7 April 2024
Sunday, April 7 – Round Up
Switzerland may fund French nuclear projects as it grapples with internal issues in the news this Sunday morning.

Swiss Employers Association: Increase Retirement Ages

8 April 2024
Swiss Employers Association: Increase Retirement Ages
Following the rejection of a pension initiative, the Swiss Employers' Association (SAV) recommends a gradual raise in retirement age to 66.

Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec

12 April 2024
Diehl Defence Will Develop Drones For Swiss Defence Firm Skysec
Diehl Defence collaborates with Skysec Defence under a new agreement to enhance drone defense capabilities for military use.

Zurich VC Lakestar Secures $600 Million In New Funds

12 April 2024
Zurich VC Lakestar Secures $600 Million In New Funds
Lakestar successfully closes two new funds, accumulating $600 million, to advance Europe's digital sovereignty.

Stay in Touch!

Noteworthy

Thai Central Group to Allegedly Takeover KaDeWe
Thai Central Group to Allegedly Takeover KaDeWe
12 April 2024
Leonteq and Raiffeisen Extend Partnership
Leonteq and Raiffeisen Extend Partnership
12 April 2024